Status:

COMPLETED

Metabolomic Effects of Probiotics Administration

Lead Sponsor:

Probiotical S.p.A.

Collaborating Sponsors:

University of Florence

Conditions:

Metabolomic Profile

Eligibility:

All Genders

24-65 years

Phase:

NA

Brief Summary

Background: The establishment of the beneficial interactions between the host and its microbiota is essential for the development and correct functioning of the organism, since microflora alterations ...

Detailed Description

Design: In a first phase twenty-two healthy subjects are enrolled in the study and administered with Lactobacillus delbrueckii subs. delbrueckii and/or a mix of 5 biotypes of Bifidobacterium longum fo...

Eligibility Criteria

Inclusion

  • \- healthy subjects

Exclusion

  • previous surgery on the intestinal tract;
  • a probiotic / prebiotic and antibiotic treatments within 3 and 1 months, respectively, before the beginning of the study;
  • subjects have changed drastically their diet or lifestyle during the study.

Key Trial Info

Start Date :

April 20 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 31 2021

Estimated Enrollment :

42 Patients enrolled

Trial Details

Trial ID

NCT04506385

Start Date

April 20 2020

End Date

March 31 2021

Last Update

January 25 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Azienda Ospedaliera-Universitaria Maggiore della carità di Novara

Novara, Piedmont, Italy, 28100